Jasmine Lee

Experts / Jasmine Lee

Jasmine Lee is a pharmacist, and PhD candidate at the University of Sydney.

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Obstetrics and gynaecology, Women's health

Clinical Articles

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

By A/Prof Nial Wheate, Jasmine Lee

Clinical Articles

Obstetrics and gynaecology, Women's health

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

By Prof Nial Wheate, Jasmine Lee

Clinical Articles

Drugs and devices

Jasmine Lee

More from this expert

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Jasmine Lee

More from this expert

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Ryeqo approved for endometriosis

Ryeqo has been available in Australia since 2022, but until now was not specifically indicated for endometriosis. Here's how it works and what you need to be aware of.

Can the hair-loss drug finasteride affect mental health?

Here's what the evidence says about the risks...

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.